Literature DB >> 11183901

Overactive bladder significantly affects quality of life.

P Abrams, C J Kelleher, L A Kerr, R G Rogers.   

Abstract

Overactive bladder (OAB), with symptoms of frequency, urgency, and urge incontinence, substantially affects the lives of millions of people. The symptoms associated with OAB can significantly affect the social, psychological, occupational, domestic, physical, and sexual aspects of those who suffer from it. Unfortunately, many sufferers are reluctant to discuss their condition with their healthcare provider or family members. As a result, OAB remains underreported, despite increased awareness and improved diagnosis and treatment. Health-related quality of life can be measured objectively, and several instruments have been developed, validated, and used in research. Currently, there are 2 major types of quality-of-life questionnaires: generic and disease specific. Although these questionnaires have been helpful and are widely used, the goal is to establish a single questionnaire that is acceptable throughout the world for use by urologists, gynecologists, urogynecologists, geriatricians, and epidemiologists.

Entities:  

Mesh:

Year:  2000        PMID: 11183901

Source DB:  PubMed          Journal:  Am J Manag Care        ISSN: 1088-0224            Impact factor:   2.229


  107 in total

1.  Assessment of the relative in vivo potency of the hydroxylated metabolite of darifenacin in its ability to decrease salivary flow using pooled population pharmacokinetic-pharmacodynamic data.

Authors:  Thomas Kerbusch; Peter A Milligan; Mats O Karlsson
Journal:  Br J Clin Pharmacol       Date:  2004-02       Impact factor: 4.335

2.  Fluid manipulation among individuals with lower urinary tract symptoms: a mixed methods study.

Authors:  Emily A Elstad; Nancy N Maserejian; John B McKinlay; Sharon L Tennstedt
Journal:  J Clin Nurs       Date:  2010-11-15       Impact factor: 3.036

Review 3.  Translational Research and Functional Changes in Voiding Function in Older Adults.

Authors:  Florenta Aura Kullmann; Lori Ann Birder; Karl-Erik Andersson
Journal:  Clin Geriatr Med       Date:  2015-07-23       Impact factor: 3.076

4.  Impact of Dry Mouth on Fluid Intake and Overactive Bladder Symptoms in Women taking Fesoterodine.

Authors:  Steven J Weissbart; Rusell Lewis; Ariana L Smith; Heidi S Harvie; Janis M Miller; Lily A Arya
Journal:  J Urol       Date:  2015-12-10       Impact factor: 7.450

Review 5.  [Epidemiology and pathophysiology of overactive bladder].

Authors:  S Schumacher
Journal:  Urologe A       Date:  2006-07       Impact factor: 0.639

6.  Effectiveness and tolerability of extended-release oxybutynin vs extended-release tolterodine in women with or without prior anticholinergic treatment for overactive bladder.

Authors:  Rodney U Anderson; Scott MacDiarmid; Sherron Kell; James H Barada; Scott Serels; Roger P Goldberg
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2006-05-03

7.  Cost-effectiveness of mirabegron compared to tolterodine ER 4 mg for overactive bladder in Canada.

Authors:  Sender Herschorn; Jameel Nazir; Barbara Ramos; Zalmai Hakimi
Journal:  Can Urol Assoc J       Date:  2017 Mar-Apr       Impact factor: 1.862

Review 8.  Global perspective of treatment failures.

Authors:  Sender Herschorn
Journal:  Can Urol Assoc J       Date:  2013-09       Impact factor: 1.862

Review 9.  Perspectives on overactive bladder in the elderly population.

Authors:  Masaki Yoshida
Journal:  World J Urol       Date:  2009-11-11       Impact factor: 4.226

10.  The evolution of transdermal/ topical overactive bladder therapy and its benefits over oral therapy.

Authors:  Scott A Macdiarmid
Journal:  Rev Obstet Gynecol       Date:  2009
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.